756525-97-0Relevant articles and documents
Lectin receptor mediated cancer pre-targeted treatment medicine
-
Paragraph 0108; 0109, (2018/07/30)
The invention provides cancer treatment prodrug based on a lectin receptor pre-targeting strategy. The cancer treatment prodrug is prodrug of anthracycline anti-tumor antibiotics. The medicine has a structure shown as a formula I in the description. The invention also provides a medicine composition and application of the compound.